Solubility parameter based drug delivery system and method for altering drug saturation concentration.
Abstract
The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
236 members in 29 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 72234291 | United States of America | A | |
| 9205297 | United States of America | W |
Members236
| Document | Office | Kind | |
|---|---|---|---|
| US4814168A | United States of America | A | |
| WO8907950A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3284789A | Australia | A | |
| DK549489D0 | Denmark | D0 | |
| DK549489A | Denmark | A | |
| IE900089L | Ireland | L | |
| IE900090L | Ireland | L | |
| CA2044132A1 | Canada | A1 | |
| CA2044170A1 | Canada | A1 | |
| EP0379044A1 | European Patent Office (EPO) | A1 | |
| EP0379045A1 | European Patent Office (EPO) | A1 | |
| WO9007939A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9007940A1 | World Intellectual Property Organization (WIPO) | A1 | |
| PT92829A | Portugal | A | |
| PT92830A | Portugal | A | |
| KR900700141A | Republic of Korea | A | |
| AU5034990A | Australia | A | |
| AU5093790A | Australia | A | |
| NL9020159A | Netherlands (Kingdom of the) | A | |
| NL9020171A | Netherlands (Kingdom of the) | A | |
| AU606840B2 | Australia | B2 | |
| US4994267A | United States of America | A | |
| US4994278A | United States of America | A | |
| CA2025033A1 | Canada | A1 | |
| EP0418248A1 | European Patent Office (EPO) | A1 | |
| US5032207A | United States of America | A | |
| JPH03503283A | Japan | A | |
| WO9114463A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP0453505A1 | European Patent Office (EPO) | A1 | |
| EP0453517A1 | European Patent Office (EPO) | A1 | |
| EP0474647A1 | European Patent Office (EPO) | A1 | |
| AU622776B2 | Australia | B2 | |
| JPH04502719A | Japan | A | |
| JPH04504515A | Japan | A | |
| CA2104474A1 | Canada | A1 | |
| WO9215289A1 | World Intellectual Property Organization (WIPO) | A1 | |
| NO923699D0 | Norway | D0 | |
| FI924313A | Finland | A | |
| FI924313A7 | Finland | A7 | |
| FI924313L | Finland | L | |
| AU1461092A | Australia | A | |
| CA2109099A1 | Canada | A1 | |
| WO9219451A1 | World Intellectual Property Organization (WIPO) | A1 | |
| BR9008012A | Brazil | A | |
| KR920703220A | Republic of Korea | A | |
| AU2004092A | Australia | A | |
| AU632534B2 | Australia | B2 | |
| CA2110914A1 | Canada | A1 | |
| WO9300058A1 | World Intellectual Property Organization (WIPO) | A1 | |
| IL102277D0 | Israel | D0 | |
| AU2268992A | Australia | A | |
| NO923699L | Norway | L | |
| US5234957A | United States of America | A | |
| FI933761A | Finland | A | |
| FI933761L | Finland | L | |
| NO933296D0 | Norway | D0 | |
| NO933296L | Norway | L | |
| NZ243200A | New Zealand | A | |
| NO934523D0 | Norway | D0 | |
| EP0573576A1 | European Patent Office (EPO) | A1 | |
| FI935833A | Finland | A | |
| FI935833L | Finland | L | |
| EP0379044B1 | European Patent Office (EPO) | B1 | |
| EP0418248B1 | European Patent Office (EPO) | B1 | |
| AT99175T | Austria | T | |
| AT99176T | Austria | T | |
| ATE99175T1 | Austria | T1 | |
| ATE99176T1 | Austria | T1 | |
| DE68911920D1 | Germany | D1 | |
| DE69005461D1 | Germany | D1 | |
| NO934523LThis record | Norway | L | |
| EP0592481A4 | European Patent Office (EPO) | A4 | |
| DK0379044T3 | Denmark | T3 | |
| ES2048326T3 | Spain | T3 | |
| US5300291A | United States of America | A | |
| EP0591432A1 | European Patent Office (EPO) | A1 | |
| EP0592481A1 | European Patent Office (EPO) | A1 | |
| DE69005461T2 | Germany | T2 | |
| DE68911920T2 | Germany | T2 | |
| US5332576A | United States of America | A | |
| JPH06508820A | Japan | A | |
| JPH06510279A | Japan | A | |
| BR9206208A | Brazil | A | |
| CA2126366A1 | Canada | A1 | |
| IE940503A1 | Ireland | A1 | |
| EP0634179A1 | European Patent Office (EPO) | A1 | |
| MX9203648A | Mexico | A | |
| CA2170504A1 | Canada | A1 | |
| WO9505813A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7672294A | Australia | A | |
| IL112269D0 | Israel | D0 | |
| US5405486A | United States of America | A | |
| AU658870B2 | Australia | B2 | |
| EP0379045B1 | European Patent Office (EPO) | B1 | |
| AT122240T | Austria | T | |
| ATE122240T1 | Austria | T1 | |
| EP0591432A4 | European Patent Office (EPO) | A4 | |
| DE69019175D1 | Germany | D1 | |
| ES2071683T3 | Spain | T3 | |
| CA2180530A1 | Canada | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Patent expiredExpiredMK1K | MK1K |
Numbers
- Application
- 934523
Titles2
- English
- Solubility parameter-based drug delivery system and method for changing drug saturation concentration
- Norwegian
- Löselighetsparameterbasert medikamenttilförselssystem og fremgangsmåte til endring av medikamentets metningskonsentrasjon
Classification
- CPC, 15
- A61K9/7053
- A61K47/30
- A61F13/0276
- A61F2013/00646
- A61K9/7061
- A61K9/7069
- A61L15/18
- A61L15/58
- A61L15/585
- B26F1/384
- A61P11/06
- A61P25/02
- A61P27/06
- A61P5/30
- A61P9/10
- IPC, 8
- A61F13 00
- A61K9 70
- A61L15 00
- A61L15 16
- A61F13 02
- A61L15 18
- A61L15 26
- A61L15 58